Annual CFO
-$21.95 M
+$609.00 K+2.70%
31 December 2023
Summary:
NKGen Biotech Common Stock annual cash flow from operations is currently -$21.95 million, with the most recent change of +$609.00 thousand (+2.70%) on 31 December 2023. NKGN annual CFO is now -12.28% below its all-time high of -$19.55 million, reached on 31 December 2021.NKGN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$6.00 M
-$1.97 M-48.71%
30 June 2024
Summary:
NKGen Biotech Common Stock quarterly cash flow from operations is currently -$6.00 million, with the most recent change of -$1.97 million (-48.71%) on 30 June 2024. Over the past year, it has dropped by -$1.43 million (-31.41%). NKGN quarterly CFO is now -48.71% below its all-time high of -$4.03 million, reached on 31 March 2024.NKGN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$21.54 M
-$469.00 K-2.23%
30 June 2024
Summary:
NKGen Biotech Common Stock TTM cash flow from operations is currently -$21.54 million, with the most recent change of -$469.00 thousand (-2.23%) on 30 June 2024. Over the past year, it has dropped by -$6.53 million (-43.49%). NKGN TTM CFO is now -43.49% below its all-time high of -$15.01 million, reached on 30 September 2023.NKGN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKGN Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.7% | -31.4% | -43.5% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
NKGN Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -12.3% | +2.7% | -48.7% | +64.9% | -43.5% | +21.8% |
| 5 y | 5 years | -12.3% | +2.7% | -48.7% | +64.9% | -43.5% | +21.8% |
| alltime | all time | -12.3% | +2.7% | -48.7% | +64.9% | -43.5% | +21.8% |
NKGen Biotech Common Stock Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$6.00 M(+48.7%) | -$21.54 M(+2.2%) |
| Mar 2024 | - | -$4.03 M(-41.9%) | -$21.07 M(-4.0%) |
| Dec 2023 | -$21.95 M | -$6.94 M(+52.0%) | -$21.95 M(+46.2%) |
| Sept 2023 | - | -$4.57 M(-17.5%) | -$15.01 M(-45.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$5.53 M(+12.5%) | -$27.54 M(+25.1%) |
| Mar 2023 | - | -$4.91 M(-71.2%) | -$22.00 M(+28.8%) |
| Dec 2022 | -$22.56 M(+15.4%) | - | - |
| Sept 2022 | - | -$17.09 M | -$17.09 M |
| Dec 2021 | -$19.55 M | - | - |
FAQ
- What is NKGen Biotech Common Stock annual cash flow from operations?
- What is the all time high annual CFO for NKGen Biotech Common Stock?
- What is NKGen Biotech Common Stock annual CFO year-on-year change?
- What is NKGen Biotech Common Stock quarterly cash flow from operations?
- What is the all time high quarterly CFO for NKGen Biotech Common Stock?
- What is NKGen Biotech Common Stock quarterly CFO year-on-year change?
- What is NKGen Biotech Common Stock TTM cash flow from operations?
- What is the all time high TTM CFO for NKGen Biotech Common Stock?
- What is NKGen Biotech Common Stock TTM CFO year-on-year change?
What is NKGen Biotech Common Stock annual cash flow from operations?
The current annual CFO of NKGN is -$21.95 M
What is the all time high annual CFO for NKGen Biotech Common Stock?
NKGen Biotech Common Stock all-time high annual cash flow from operations is -$19.55 M
What is NKGen Biotech Common Stock annual CFO year-on-year change?
Over the past year, NKGN annual cash flow from operations has changed by +$609.00 K (+2.70%)
What is NKGen Biotech Common Stock quarterly cash flow from operations?
The current quarterly CFO of NKGN is -$6.00 M
What is the all time high quarterly CFO for NKGen Biotech Common Stock?
NKGen Biotech Common Stock all-time high quarterly cash flow from operations is -$4.03 M
What is NKGen Biotech Common Stock quarterly CFO year-on-year change?
Over the past year, NKGN quarterly cash flow from operations has changed by -$1.43 M (-31.41%)
What is NKGen Biotech Common Stock TTM cash flow from operations?
The current TTM CFO of NKGN is -$21.54 M
What is the all time high TTM CFO for NKGen Biotech Common Stock?
NKGen Biotech Common Stock all-time high TTM cash flow from operations is -$15.01 M
What is NKGen Biotech Common Stock TTM CFO year-on-year change?
Over the past year, NKGN TTM cash flow from operations has changed by -$6.53 M (-43.49%)